James B. Tananbaum is Director at CRITICAL THERAPEUTICS INC (CRTX). They have made 5 open-market trades across 2 companies since 2006, most recently 2007-06-14.
CIK 0001162061
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CRTX | SELL | 2007-06-14 | 2007-06-18 | $2.29 | $448K | +30.4% | +64.5% | +64.5% |
| CRTX | SELL | 2007-06-11 | 2007-06-13 | $2.26 | $820K | +30.4% | +64.5% | +64.5% |
| CRTX | SELL | 2007-06-06 | 2007-06-08 | $2.60 | $1.6M | +30.4% | +64.5% | +64.5% |
| CRTX | SELL | 2007-06-01 | 2007-06-05 | $2.78 | $3.1M | +30.4% | +64.5% | +64.5% |
| VNDA | SELL | 2006-12-11 | 2006-12-13 | $26.55 | $19.8M | -4.3% | -1.1% | -1.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.